CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma. Araujo-Ayala F, Ros M, Alexandru R, Mateos-Jaimez J, et al. Blood 2026 Jul 22:blood.2025032663. doi: 10.1182/blood.2025032663.

Read + Share

Amedeo Smart

Independent Medical Education

Araujo-Ayala F, Ros M, Alexandru R, Mateos-Jaimez J, et al. CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma. Blood 2026 Jul 22:blood.2025032663. doi: 10.1182/blood.2025032663.
PMID: 42485767